Craft

Cybin

Stock Price

$10.5

2024-10-29

Market Capitalization

$209.9 M

2024-10-29

Cybin Summary

Company Summary

Overview
Cybin formerly known as (Clarmin Explorations) is a biopharmaceutical company that focuses on developing psychedelic-based therapeutics. It offers drug development, supplements, active pharmaceutical ingredients, engineers drug discovery platforms, drug delivery systems, formulation approaches and treatment regimens, etc. The company treats mental health and alcohol use disorders.
Type
Public
Status
Active
Founded
2019
HQ
Toronto, CA | view all locations
Website
https://cybin.com
Cybersecurity rating
Sectors

Key People

  • Doug Drysdale

    Doug Drysdale, Chief Executive Officer

  • Aaron Bartlone

    Aaron Bartlone, Chief Operating Officer

  • Alex Nivorozhkin

    Alex Nivorozhkin, Chief Scientific Officer

  • Brett Greene

    Brett Greene, Chief Innovations Officer

Operating MetricsView all

Trademarks

24
9.1%

FY, 2023

Non-Revenue Generating Projects

4

FY, 2023

Drug Programs

3

Jul, 2023

LocationsView all

2 locations detected

  • Toronto, ON HQ

    Canada

    5600-100 King St West

  • Dublin, D

    Ireland

    One Spencer Dock, North Wall Quay

Cybin Financials

Summary Financials

Net income (Q3, 2026)
($C42.7M)
Cash (Q3, 2026)
$C195.1M
EBIT (Q3, 2026)
($C44.2M)

Footer menu